Skip to main content

Table 3 Baseline serum parameters in each homofilter

From: Comparison of two polysulfone membranes for continuous renal replacement therapy for sepsis: a prospective cross-over study

Serum parameters Total (n = 8) SHG → AEF (n = 4) AEF → SHG (n = 4)
PaO2/FiO2 ratio, Torr 260 (180–375) 260 (191–273) 309 (171–456)
pH 7.38 (7.26–7.44) 7.40 (7.31–7.50) 7.32 (7.22–7.43)
Bicarbonate 18.9 (16.7–23.7) 18.7 (16.7–21.3) 21.0 (12.1–35.9)
Bilirubin, mmol/L 0.8 (0.2–1.6) 1.1 (0.3–1.6) 0.5 (0.2–2.7)
Creatinine, mg/dL (μmol/L) 2.3 (1.3–3.3) 1.8 (0.9–2.5) 2.9 (1.5–4.8)
Urea, mg/dL 66 (33–76) 51 (23–79) 70 (41–76)
Sodium, mEq/L 142 (136–147) 142 (137–142) 143 (136–150)
Potassium, mEq/L 4.0 (3.1–4.6) 3.5 (3.1–4.4) 4.3 (3.3–5.6)
Creatine kinase, IU/L 618 (117–1319) 871 (203–3717) 512 (100–974)
Myoglobin, ng/ml 3059 (478–6528) 3609 (1242–11,901) 1745 (389–6253)
HMGB-1, ng/ml 6.9 (5.6–13.0) 9.2 (6.4–13.0) 5.7 (4.8–85.4)
Hematocrit, % 30.8 (25.1–36.4) 34.0 (26.5–37.6) 28.0 (25.1–33.3)
Plate count, 103/μL 9.8 (7.6–16.3) 9.2 (6.9–14.5) 13.2 (7.8–21.0)
  1. Data are presented as median (IQR) or n (%)
  2. HMGB-1 high mobility group box-1, IQR interquartile rang